- Recognized for unique technology such as epigenetic biomarker selective gene amplification
- Tax benefits for 5 years

On September 30th, Sunsun Biomaterials (CEO Park Hee-kyung), a company specializing in molecular diagnostics based on gene and epigenome, announced that it had been designated as a high-tech company in the Special Research and Development Zone.

'High-tech company' refers to a company that develops, produces, and sells products in technology fields with high technology intensity and rapid technological innovation, such as information communication, biotechnology, and nanotechnology, among companies located in special R&D zones across the country, including Daejeon. The Ministry of Science, ICT and Future Planning is designated by the Ministry of Science and ICT when it meets the requirements such as high-level advanced technology, product patent rights, sales ratio generated based on these factors, and R&D expense ratio.

When a high-tech company is designated, tax benefits such as 100% reduction in corporate tax for 3 years, 50% reduction for the next 2 years, acquisition tax exemption, 100% reduction or exemption for property tax for 7 years, and 50% reduction for the next 3 years are given. also receive

This is not the first time that Sunsun Biomaterials has been certified for cutting-edge technology. Starting with ‘mutation-preferred amplification technology’ in 2018, ‘biomarker-preferred amplification and diagnostic technology’ for molecular diagnosis in 2021 received advanced technology certification from the Ministry of Trade, Industry and Energy.

'Biomarker-preferred amplification and diagnosis technology' is a molecular diagnostic technology that can determine whether or not a disease exists by selectively amplifying only biomarkers, which are indicators of epigenetic genetic diseases such as cancer. It was created based on know-how.

The advantage of this technology is that it can simultaneously detect multiple genetic mutations or genes within 2 hours with the real-time gene amplification method, a generalized molecular diagnostic method. In addition, since only target genes can be selectively amplified, it is very useful for early diagnosis of intractable diseases by detecting epigenetic biomarkers present in trace amounts in the early stages of disease onset.

Since its foundation, SEASUN BIOMATERIALS has been focusing on developing high-sensitivity molecular diagnostic technology and products. Various molecular diagnostics include cancer diagnosis due to genetic and epigenetic genetic mutations, immuno-anticancer drug responsiveness prediction diagnosis, and non-invasive prenatal diagnostic test using fetal chromosomes. have a product line.
‘U-TOP MSI Detection Kit’, a microsatellite instability (MSI) genotype screening product that determines whether to prescribe immunotherapy, was selected as a next-generation world-class product by the Ministry of Trade, Industry and Energy in 2019. The Patio NIPT detection kit, a non-invasive fetal screening test (NIPT) that detects chromosomal abnormalities in a fetus before childbirth, is the only product approved by the Ministry of Food and Drug Safety in Korea.

Recently, the field has been expanded to develop a panel (test kit) for diagnosing intractable diseases based on epigenetic genetic mutation biomarkers caused by environmental factors, and is also concentrating on the development of companion diagnostics for immuno-oncology or prognosis prediction diagnostic kits. .